From October 1, 2023 to December 31, 2023, the company has repurchased 17,500 shares, representing 1.26% for $0.08 million. With this, the company has completed the repurchase of 57,500 shares, representing 4.05% for $0.27 million under the buyback announced on June 12, 2023.
Creative Medical Technology Holdings, Inc.
Equities
CELZ
US22529Y4089
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.44 USD | +1.25% | -7.89% | -3.69% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.69% | 6.02M | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.40% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- CELZ Stock
- News Creative Medical Technology Holdings, Inc.
- Tranche Update on Creative Medical Technology Holdings, Inc.'s Equity Buyback Plan announced on June 12, 2023.